19-53258844-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_173856.2(VN1R2):c.469G>T(p.Asp157Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000554 in 1,614,136 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_173856.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VN1R2 | NM_173856.2 | c.469G>T | p.Asp157Tyr | missense_variant | 1/1 | ENST00000341702.3 | NP_776255.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VN1R2 | ENST00000341702.3 | c.469G>T | p.Asp157Tyr | missense_variant | 1/1 | NM_173856.2 | ENSP00000351244 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000447 AC: 68AN: 152148Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000506 AC: 127AN: 250930Hom.: 0 AF XY: 0.000501 AC XY: 68AN XY: 135844
GnomAD4 exome AF: 0.000565 AC: 826AN: 1461870Hom.: 0 Cov.: 32 AF XY: 0.000534 AC XY: 388AN XY: 727234
GnomAD4 genome AF: 0.000447 AC: 68AN: 152266Hom.: 0 Cov.: 32 AF XY: 0.000282 AC XY: 21AN XY: 74458
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 31, 2022 | The c.469G>T (p.D157Y) alteration is located in exon 1 (coding exon 1) of the VN1R2 gene. This alteration results from a G to T substitution at nucleotide position 469, causing the aspartic acid (D) at amino acid position 157 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at